← Back to headlines
Zai Lab Limited Gains EMA Orphan Drug Designation for Cancer Therapy
Zai Lab Limited (ZLAB) has received Orphan Drug Designation from the European Medicines Agency (EMA) for its DLL3-targeting cancer therapy.
30 Jun, 13:07 — 30 Jun, 13:07
Sources
Showing 1 of 1 sources
Related Stories
Germany Accuses Russia of Orchestrating Failed Drone Attack on Leipzig Airport
40m ago
Norway’s King Haakon VIII Takes Oath in Parliament
41m ago
India Defies International Court Ruling Over Indus Waters Treaty Dispute
42m ago
Israeli Strike in Gaza Captures Senior Hamas Official Amid Civilian Deaths
42m ago